| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Immunology of Infectious Disease Medical Research Council/University of Cape Town Unit, Institute of Infectious Disease and Molecular Medicine, Health Science Faculty, University of Cape Town, Cape Town, South Africa;
Department of Cellular and Molecular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie, Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussels, Brussels, Belgium;
Centre National de la Recherché Scientifique, Molecular Immunology and Embryology, Orléans, France; and
Unit of Entomology, Institute of Tropical Medicine, Antwerp, Belgium
The initial host response toward the extracellular parasite Trypanosoma brucei is characterized by the early release of inflammatory mediators associated with a type 1 immune response. In this study, we show that this inflammatory response is dependent on activation of the innate immune system mediated by the adaptor molecule MyD88. In the present study, MyD88-deficient macrophages are nonresponsive toward both soluble variant-specific surface glycoprotein (VSG), as well as membrane-bound VSG purified from T. brucei. Infection of MyD88-deficient mice with either clonal or nonclonal stocks of T. brucei resulted in elevated levels of parasitemia. This was accompanied by reduced plasma IFN-
and TNF levels during the initial stage of infection, followed by moderately lower VSG-specific IgG2a Ab titers during the chronic stages of infection. Analysis of several TLR-deficient mice revealed a partial requirement for TLR9 in the production of IFN- and VSG-specific IgG2a Ab levels during T. brucei infections. These results implicate the mammalian TLR family and MyD88 signaling in the innate immune recognition of T. brucei.
This article has been cited by other articles:
|
|
 |
|
  T. R. Dagenais, B. E. Freeman, K. P. Demick, D. M. Paulnock, and J. M. Mansfield Processing and Presentation of Variant Surface Glycoprotein Molecules to T Cells in African Trypanosomiasis J. Immunol., September 1, 2009; 183(5): 3344 - 3355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guilliams, K. Movahedi, T. Bosschaerts, T. VandenDriessche, M. K. Chuah, M. Herin, A. Acosta-Sanchez, L. Ma, M. Moser, J. A. Van Ginderachter, et al. IL-10 Dampens TNF/Inducible Nitric Oxide Synthase-Producing Dendritic Cell-Mediated Pathogenicity during Parasitic Infection J. Immunol., January 15, 2009; 182(2): 1107 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Dagenais, K. P. Demick, J. D. Bangs, K. T. Forest, D. M. Paulnock, and J. M. Mansfield T-Cell Responses to the Trypanosome Variant Surface Glycoprotein Are Not Limited to Hypervariable Subregions Infect. Immun., January 1, 2009; 77(1): 141 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lopez, K. P. Demick, J. M. Mansfield, and D. M. Paulnock Type I IFNs Play a Role in Early Resistance, but Subsequent Susceptibility, to the African Trypanosomes J. Immunol., October 1, 2008; 181(7): 4908 - 4917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Bartholomeu, C. Ropert, M. B. Melo, P. Parroche, C. F. Junqueira, S. M. R. Teixeira, C. Sirois, P. Kasperkovitz, C. F. Knetter, E. Lien, et al. Recruitment and Endo-Lysosomal Activation of TLR9 in Dendritic Cells Infected with Trypanosoma cruzi J. Immunol., July 15, 2008; 181(2): 1333 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Leppert, J. M. Mansfield, and D. M. Paulnock The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling J. Immunol., July 1, 2007; 179(1): 548 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Harris, J. M. Mansfield, and D. M. Paulnock CpG Oligodeoxynucleotide Treatment Enhances Innate Resistance and Acquired Immunity to African Trypanosomes Infect. Immun., May 1, 2007; 75(5): 2366 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs J. Exp. Med., April 16, 2007; 204(4): 893 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Namangala, C. Sugimoto, and N. Inoue Effects of Exogenous Transforming Growth Factor {beta} on Trypanosoma congolense Infection in Mice Infect. Immun., April 1, 2007; 75(4): 1878 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caljon, J. Van Den Abbeele, B. Stijlemans, M. Coosemans, P. De Baetselier, and S. Magez Tsetse Fly Saliva Accelerates the Onset of Trypanosoma brucei Infection in a Mouse Model Associated with a Reduced Host Inflammatory Response Infect. Immun., November 1, 2006; 74(11): 6324 - 6330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bafica, H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection J. Immunol., September 15, 2006; 177(6): 3515 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Harris, N. M. Cooney, J. M. Mansfield, and D. M. Paulnock Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect. Immun., August 1, 2006; 74(8): 4530 - 4537. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
